-0.00103535763602186 -0.00117931726283231 -0.000977773785297514 1.15167701435921E-06 0.000401359439547801 0.00377289389945157 -0.00212945079978225 -0.00604515264902991
Sign Up Today X
Thanks for submitting the form.
Stockreport

FDA Approves Neuralink Rival’s Brain Implant [Forbes]

Amazon.com, Inc. (AMZN)  More Company Research Source: Forbes
Last amazon.com, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml%3fc%3d97664%26p%3dirol-irhome
created by a cofounder of Elon Musk's Neuralink that claims its implant could be used to assist patients with severe paralysis—a clearance that comes as biotech companies reportedly face challenges for regulatory approval under the Trump administration. Key Facts Precision said Thursday the FDA approved its Layer 7 Cortical Interface, a component of the company's brain-computer interface implant that helps record, monitor and stimulate electrical activity on the brain's surface. The FDA's clearance allows Precision to implant Layer 7 in patients for up to 30 days and market the technology for use in clinical applications, including during procedures to map brain signals, the company said. Precision announced it will expand its clinical research program for the implant, after the company had already tested the device in 37 patients, as the FDA's approval allows Precision to collect data over weeks instead of hours. A spokesperson for Precision told Bloomberg the company expec [Read more]
IMPACT SNAPSHOT EVENT TIME: AMZN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
AMZN alerts
from News Quantified
AMZN
NEWS
AMZN
Earnings
AMZN
Analyst Actions
AMZN
SEC Filings
Stockreport

FDA Approves Neuralink Rival’s Brain Implant [Forbes]

Amazon.com, Inc.  (AMZN) 
More Company Research Source: Forbes
Last amazon.com, inc. earnings: 4/30 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: phx.corporate-ir.net/phoenix.zhtml%3fc%3d97664%26p%3dirol-irhome
created by a cofounder of Elon Musk's Neuralink that claims its implant could be used to assist patients with severe paralysis—a clearance that comes as biotech companies reportedly face challenges for regulatory approval under the Trump administration. Key Facts Precision said Thursday the FDA approved its Layer 7 Cortical Interface, a component of the company's brain-computer interface implant that helps record, monitor and stimulate electrical activity on the brain's surface. The FDA's clearance allows Precision to implant Layer 7 in patients for up to 30 days and market the technology for use in clinical applications, including during procedures to map brain signals, the company said. Precision announced it will expand its clinical research program for the implant, after the company had already tested the device in 37 patients, as the FDA's approval allows Precision to collect data over weeks instead of hours. A spokesperson for Precision told Bloomberg the company expec [Read more]
IMPACT SNAPSHOT
EVENT TIME:
AMZN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Don't Miss Out On The Next BIG Stock Move
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
 POST NEWS RANGE
%
PRICE CHANGE
PRICE CHANGE PERCENTAGE
S&P 500 (SPX)
%
 VOLUME RATIO
%
VOLUME (SHARES)
TICKS
AVG SHARES PER TRADE
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS